All lobbying filings

CROSSROADS STRATEGIES, LLC

Lobbying for HALEON US HOLDINGS LLC · consumer health care company

Filing 1st Quarter - Report

1st Quarter (Jan 1 - Mar 31) 2025 · New Jersey · House · Senate · $50,000.00 income · posted Apr 20, 2025

Official filing document

Bills named in this filing 1

HR 1968
Full-Year Continuing Appropriations and Extensions Act, 2025

Lobbying activity 3

Health Issues

Issues related to healthcare and payment for over-the-counter drugs; General education of over-the-counter switches, including reauthorization of the Over-the-Counter Monograph Drug User Fee Act and policies impacting a Nonprescription Drug Product with an Additional Condition for Nonprescription Use.

Taxation/Internal Revenue Code

Issues related to coverage of over-the-counter products with FSAs and HSAs; H.R.1968, Full-Year Continuing Appropriations and Extensions Act, 2025 (P.L.119-4).

Budget/Appropriations

Policies impacting access to over-the-counter products; H.R.1968, Full-Year Continuing Appropriations and Extensions Act, 2025 (P.L.119-4).

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.